SW Ohio startup Enable Injections is aiming to build a new 150,000-square-foot headquarters as the company plans to more than double its headcount in the next five years.
Mike Hooven, the company’s president and CEO, confirmed Enable will start looking for a site to build a state-of-the-art facility in mid-2023. It’s the first time he’s talked in detail about the company’s future needs. Enable, which is developing a device called the enFuse, a wearable drug-delivery device, is quickly moving…